2025 Child and Adolescent Psychiatry Conference

Objectives (Educational Content) :

1. Differentiate ADHD from other conditions that might present in a similar way and apply practical case-based earning to integrate diagnostic reasoning and treatment planning in real-world clinical scenarios.

2. Develop effective, guideline-based treatment plans for behavioral health disorders, including pharmacologic and non pharmacologic interventions appropriate for the primary care setting.

3. Recognize evolving trends in youth marijuana and THC abuse and understand why adolescents are developmentally vulnerable to THC use and its effects.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.

Identified Gap:

Pediatric providers need enhanced skills to accurately differentiate ADHD from other conditions, apply case-based diagnostic reasoning, and develop guideline-based treatment plans for behavioral health disorders. Education is also needed to increase awareness of evolving trends in adolescent marijuana and THC use, including understanding developmental vulnerabilities and associated risks, to inform prevention and counseling strategies.

Estimated Time to Complete the Educational Activity:

6 hour(s)

Expiration Date for CE/CME Credit:

12-20-2025

Method of Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.

Disclosure:

The speakers have returned the disclosure form, indicating that the following financial relationships with ineligible companies. All financial relationships have been mitigated. The speakers have returned the disclosure form, indicating that there are no financial relationships with ineligible companies: Sumru Bilge-Johnson, MD, FAPA, DFAACAP. Jeffrey Smith, MD Laura Markley, MD, FAPA, FACLP, FAAP, FASAM. Mike Redovian, MD. Susan Neilan, MD, JD. Selena Magalotti, MD, FAPA. Laura Hlavaty, PhD, PMH-C. Chelsea Weyand, PsyD, ABPP. Elena Hissett, MD. Eva Szigethy, MD, PhD. Gabrielle Carlson, MD.

Accreditation Statement:

Akron Children’s Hospital is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

Akron Children’s Hospital designates this enduring material activity for a maximum of 6.0 AMA PRA Category 1 Credits TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Bibliography:

1. Dretzke, J., Frew, E., Davenport, C., Barlow, J., Stewart-Brown, S. L., Sandercock, J., Bayliss, S., Raftery, J., Hyde, C., & Taylor, R. (2005). The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technology Assessment, 9(50), 1-250.

2. Walter, H. J., Abright, A. R., Bukstein, O. G., Diamond, J., Keable, H., Ripperger-Suhler, J., & Rockhill, C. (2023). Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 62(5), 479–502. https://doi.org/10.1016/j.jaac.2022.10.001

3. Chocron, Y., Zuber, J. P., & Vaucher, J. (2019). Cannabinoid hyperemesis syndrome. BMJ, 366, l4336. https://doi.org/10.1136/bmj.l4336